An update on treatment of onychomycosis

被引:40
作者
Grover, Chander [1 ]
Khurana, Ananta [1 ]
机构
[1] Univ Coll Med Sci, Delhi 110095, India
关键词
Antifungal agents; keratinophilic fungi; tinea unguium; AMOROLFINE NAIL LACQUER; DISTAL SUBUNGUAL ONYCHOMYCOSIS; QUALITY-OF-LIFE; TOENAIL ONYCHOMYCOSIS; TRICHOPHYTON-RUBRUM; ANTIFUNGAL SUSCEPTIBILITY; INTERMITTENT TERBINAFINE; TOPICAL TREATMENT; ORAL TERBINAFINE; AGGRESSIVE DEBRIDEMENT;
D O I
10.1111/j.1439-0507.2012.02199.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Onychomycosis (OM) is a fungal infection of the nail plate or nail bed which is highly prevalent in the general population and also responsible for significant morbidity. The condition needs to be treated in view of the physical and emotional handicap it produces. The peculiarities of the nail apparatus in health and disease lead to difficulties in being able to successfully treat this condition. Hence, the very same antifungals which produce high cure rates in skin infections are rendered less efficacious in nail disease. Low cure rates and high relapse rates even with highly efficacious antifungals have lead to an increasing interest in exploring newer treatment options which can ensure drug penetration, drug persistence, mycological cure and effective prevention of relapse. The current review aims to summarize our current status of knowledge about the treatment options for OM. It also summarizes the newer areas of research especially with respect to devices related therapies; physical measures to enhance penetration through nail; and development and evaluation of synergistic combinations.
引用
收藏
页码:541 / 551
页数:11
相关论文
共 96 条
[1]   Ultrasound-Mediated Nail Drug Delivery System [J].
Abadi, Danielle ;
Zderic, Vesna .
JOURNAL OF ULTRASOUND IN MEDICINE, 2011, 30 (12) :1723-1730
[2]  
Alpsoy Erkan, 1996, Journal of Dermatology (Tokyo), V23, P259, DOI 10.1111/j.1346-8138.1996.tb04009.x
[3]  
Baran R, 1996, ACTA DERM-VENEREOL, V76, P82
[4]   A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region [J].
Baran, R ;
Feuilhade, M ;
Datry, A ;
Goettmann, S ;
Pietrini, P ;
Viguie, C ;
Badillet, G ;
Larnier, C ;
Czernielewski, J .
BRITISH JOURNAL OF DERMATOLOGY, 2000, 142 (06) :1177-1183
[5]   Chemical avulsion with urea nail lacquer [J].
Baran, R ;
Tosti, A .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2002, 13 (04) :161-164
[6]   Review of antifungal therapy and the severity index for assessing onychomycosis: Part I [J].
Baran, Robert ;
Hay, Rod J. ;
Garduno, Javier I. .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2008, 19 (02) :72-81
[7]   Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis [J].
Bohn, M ;
Kraemer, KT .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 43 (04) :S57-S69
[8]   Onychomycosis in children: Treatment with bifonazole-urea [J].
Bonifaz, A ;
Ibarra, G .
PEDIATRIC DERMATOLOGY, 2000, 17 (04) :310-314
[9]   EFFICACY AND SAFETY OF BIFONAZOLE UREA IN THE 2-PHASE TREATMENT OF ONYCHOMYCOSIS [J].
BONIFAZ, A ;
GUZMAN, A ;
GARCIA, C ;
SOSA, J ;
SAUL, A .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1995, 34 (07) :500-503
[10]   A Review of Current Research in Light-Based Technologies for Treatment of Podiatric Infectious Disease States [J].
Bornstein, Eric .
JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 2009, 99 (04) :348-352